Robotic Minimally Invasive Ventral Hernia Repair With DEXTER
Austria, France, Germany33 participantsStarted 2025-06-11
Plain-language summary
The aim of this clinical investigation is to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing incisional or primary ventral hernia repair.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged \> 18 years
* Planned to undergo incisional and primary midline ventral (M2-M4; epigastric, umbilical and infraumbilical) hernia repair smaller and equal to 8cm
* Patient agrees to perform the 30-day follow-up assessment, as per standard of care
Exclusion Criteria:
* Any planned concomitant procedures
* Active anticoagulant treatment
* Recurring hernia with mesh during primary hernia repair
* Need for transversal abdominal release
* Patients under corticosteroids or other immunosuppressive treatment
* Loss of domain type of hernia
* Previous incision extending from xiphoid process to pubic bone (= Median laparotomy M1 to M5)
* M2 hernia extending to M1 and/or M4 hernia extending to M5
* Ongoing intra-abdominal infection or septic state
* Abdominal fistulae
* History of major\* abdominal or pelvic surgery